Martin Michael Robert (CIK 0001837647)

Latest company ownership

AUPH - Aurinia Pharmaceuticals Inc.

Role: Chief Business Officer

Shares held

259,162

Last filed at

Mar 6, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 7, 2022	Nov 9, 2022	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Buy	95.0	+30,000	50.41%	✗	$154.8K
Mar 2, 2022	Mar 4, 2022	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	90.0	+3,651	6.54%	✗	$58.2K
Nov 9, 2021	Nov 12, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	5.0	-150,000	-55.00%	✓	$4.5M
Nov 1, 2021	Nov 3, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	10.0	-45,000	-20.28%	✓	$1.4M
Sep 20, 2021	Sep 22, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	15.0	-116,000	-17.51%	✓	$2.7M
Sep 14, 2021	Sep 16, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	17.5	-44,000	-19.92%	✓	$958.2K
Sep 13, 2021	Sep 14, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	10.0	-115,000	-24.53%	✓	$2.4M
Sep 7, 2021	Sep 8, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	37.5	-7,500	-4.07%	✓	$135.8K
Aug 26, 2021	Aug 27, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	22.5	-22,500	-10.88%	✓	$400.7K
Aug 9, 2021	Aug 10, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	41.3	-5,000	-2.36%	✓	$80.1K
Jul 28, 2021	Jul 29, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	41.3	-5,000	-2.31%	✓	$69.3K
Jun 22, 2021	Jun 23, 2021	Aurinia Pharmaceuticals Inc.	Chief Business Officer	Sell	41.3	-5,000	-2.25%	✓	$68.8K